Showing: 1 - 1 of 1 RESULTS
Transient Receptor Potential Channels

The multikinase inhibitor sorafenib is the only FDA approved drug available for advanced HCC patients, and development of second\line treatment options for patients who cannot tolerate or develop resistance to sorafenib is an urgent medical need

The multikinase inhibitor sorafenib is the only FDA approved drug available for advanced HCC patients, and development of second\line treatment options for patients who cannot …